China News Service, Ningbo, September 11 (Reporter Li Dian) "My father went to the world from here, and I came back here from the world." When talking about his return to start a business in Yuyao, Ningbo, Zhejiang, a new generation of "Ningbo Gang" Wang Jun used this paragraph Words to describe.
Wang Jun was interviewed.
Photo by Wang Gang
Wang Jun is one of the first batch of graduate students and overseas students after the reform and opening up. After obtaining a PhD in molecular biology from the University of Wisconsin, he returned to the Chinese University of Hong Kong to teach, focusing on biochemistry, molecular biology and enzyme synthesis.
In 2001, Wang Jun established Gene Harbor (Hong Kong) Biotechnology Co., Ltd. in Hong Kong to produce enzyme preparations.
Many media "explored" Gene Harbor.
Photo by Wang Gang
In 2015, at the Yonggang Forum, Wang Jun opened up the fate with his hometown.
"At that time, I had never been to Yuyao, my ancestral home. I met the teacher from Yuyao Overseas Chinese Affairs Office and soon embarked on the first journey home." Wang Jun returned to his hometown not only felt cordial, but also keenly "To the local good business environment and determination to support the development of the biomedical industry.
Wang Jun is in his seventies, but the "Four Knowledge Spirit" of the "Ningbo Gang" of "unity of knowledge and action, advancing through difficulties, knowledge of books and gifts, and knowledge of grace" is constantly spurring him.
Start a business again!
In October 2019, after several inspections, he invested in a project with an annual output of 100 tons of NMN (β-nicotinamide mononucleotide) and settled in the Sino-Italian Ningbo Ecological Park in Yuyao.
A view of Gene Harbor's production workshop.
Li Dianshe
In August of this year, the plant was officially put into operation, and the 100-ton production line was successfully tested in one run.
He told reporters that the new factory uses automation technology to complete the production and synthesis of NMN raw materials in six major steps and 12 processes. The per capita output has increased by more than three times, and the actual annual production capacity can reach 200-300 tons.
The reason for choosing this field, Wang Jun said, as the population aging trend intensifies, by 2050, the domestic population of 60 years and older will approach 500 million, and aging will reach its peak.
"China Development Report 2020" stated that the "silver economy" will become a new growth point that will drive the sustainable development of China's economy.
In addition, he also wants to promote the development of the biomedical industry in his hometown through this project.
A view of Gene Harbor's production workshop.
Li Dianshe
In Ningbo’s "246" trillion-level industrial cluster development plan, it is proposed to strive to cultivate a 100-billion-level biomedical industry development cluster by 2025.
In March of this year, Ningbo issued the "Guiding Opinions on Seizing Opportunities and Accelerating the Development of Emerging Industries in Key Fields", taking healthcare as a key development of five emerging industries.
Subsequently, the "Ningbo Biopharmaceutical Industry Cluster Cultivation Three-year Action Plan (2020-2022)" was issued. The goal is to strive to achieve a core industry scale of more than 40 billion yuan by 2022, and cultivate 2 companies with sales revenue of over 5 billion yuan and 5 companies with super 2 billion yuan leading enterprise.
"I hope that Yuyao Gene Port can become a leading company in the biomedical industry in his hometown." Wang Jun said, he is also planning to build a second phase factory covering an area of 500 acres. "By then, I hope that more people will be employed and more Return home well." (End)